VERA

Vera Therapeutics, Inc.

34.95 USD
-0.94 (-2.62%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Vera Therapeutics, Inc. stock is down -5.82% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 June’s closed higher than May. In the last 5 Unusual Options Trades, there were 4 PUTs, 1 CALL. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
30 Apr 14:19 21 Jun, 2024 35.00 PUT 223 1317
02 May 19:31 17 May, 2024 40.00 PUT 294 256
10 May 14:11 21 Jun, 2024 45.00 PUT 61 125
17 May 15:32 21 Jun, 2024 50.00 CALL 249 43
06 Jun 18:19 21 Jun, 2024 35.00 PUT 1000 1540

About Vera Therapeutics, Inc.

Vera Therapeutics, Inc. focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for immunoglobulin A nephropathy.